A new study validates a proposed new system which helps to identify and classify people with preclinical Alzheimer's disease.
Researchers discover a blood biomarker which could predict severe cognitive decline in patients with Parkinson's disease.
Researchers discover levels of certain fats found in the CSF may predict which HIV patients are more likely to suffer from cognitive impairment.
Researchers find degeneration of the fornix can identify those at risk of cognitive decline long before clinical symptoms appear.
A new test which measures the ability to name and recognize famous faces could help doctors identify early dementia in those aged 40 to 65, a new study suggests.
A new study links physical fighting and fight related injuries in teens to cognitive decline.
Researchers discover early accumulation of amyloid plaques in the temporal lobe is associated with cognitive decline. The finding could serve as a new biomarker for the early detection of Alzheimer's disease.
Caspase-2 is a key regulator of a signaling pathway which leads to cognitive decline in Alzheimer's disease, a new study finds.
Researchers suggest lifetime brain growth and early mental stimulation independently help protect against cognitive decline in multiple sclerosis.
Researchers discover by looking at amyloid-beta and tau independently that the interaction between the proteins could be the key to the cognitive decline associated with Alzheimer's disease. As the interaction between the two proteins increased, the progression of Alzheimer's worsened.
Researchers show memory pathology in older mice can be reversed by blocking the activity of a specific receptor in the brain. Blocking the B1R receptor helps recover memory and cerebrovascular function.
New research finds an increased risk for cognitive decline in patients with cardiovascular disease and type 2 diabetes.
